Depo-Medrol

November 9 2005

Depo-Medrol (Methylprednisolone acetate) is an anti-inflammatory glucocorticoid that is administered to relieve pain from rheumatoid arthritis and bursitis, severe lower back pain or dermatologic disorders. The FDA has approved use of the corticosteroid injection into a muscle, a joint, or a lesion. The FDA has not approved the use of Depo-Medrol as an epidural injection for low back pain or sciatica, though many physicians still administer it through this off-label use.

It is alleged that there have been 356 deaths and 15,000 adverse events attributed to Depo-Medrol between 1998 and 2002. Pfizer, the maker of Depo-Medrol, does not advise Epidural/Intrathecal administration (injection into spinal cord or vein) of Depo-Medrol and reports the following severe medical events associated with this usage: Arachnoiditis, Meningitis, Paraparesis/paraplegia, bowel/bladder dysfunction, seizures, headaches, and more. Other reported side effects of Depo-Medrol include congestive heart failure, osteoporosis, peptic ulcer, and convulsions.

Depo-Medrol was originally introduced for relieving pain in animals; the drug is still used by veterinarians to relieve seasonal itching and inflammation in pets - primarily dogs!

Pfizer, who manufacturers and markets Depo-Medrol (previously Pharmacia and Upjohn) recommends Depo-Medrol for a wide range of disorders including: Respiratory diseases, endocrine disorders, dermatologic diseases such as Stevens-Johnson syndrome (SJS), osteoarthritis, rheumatoid arthritis, bursitis, severe asthma, allergic rhinitis, drug hypersensitivity reactions, leukemia, lymphoma, systemic lupus, hematologic disorders, and more.

For more information on Depo-Medrol prescriptions, please [Click Here]

Register your Depo-Medrol Complaint

If you or a loved one has suffered from severe side effects or death, you may qualify for damages or remedies that may be awarded in a possible class action lawsuit. Please fill in the form to the right to submit your complaint.